What are the general treatment principles for acute lymphoblastic leukemia (ALL)?

Updated: Oct 23, 2019
  • Author: Karen Seiter, MD; Chief Editor: Koyamangalath Krishnan, MD, FRCP, FACP  more...
  • Print
Answer

Answer

Treatment recommendations for patients who are diagnosed with ALL include induction, consolidation, and maintenance therapy along with CNS prophylaxis, as follows [1, 2, 3, 4, 5] :

  • Patients receive induction therapy with combinations of drugs, including vincristine, prednisone, cyclophosphamide, doxorubicin, and L-asparaginase, which are given over 4-6 wk

  • Patients then receive consolidation (intensification) with multiagent therapy additionally, including cytarabine and methotrexate; there is no role for radiation or surgical treatment in patients in the induction phase

  • Maintenance therapy includes 6-mercaptopurine, methotrexate, steroids, and vincristine; intrathecal methotrexate is administered throughout

  • Newer studies with intensive multiagent chemotherapy (ie, the CALGB [Cancer and Leukemia Group B]- 8811 and hyper-CVAD [hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone] regimens and the ALL-2 regimen) plus the addition of TKIs for Philadelphia chromosome–positive ALL and rituximab for CD20-positive ALL have resulted in 3-y survivals of 50% or more in adults


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!